Efficacy of Tiotropium in COPD Patients with FEV1 ≥ 60% Participating in the UPLIFT® Trial

Author： Tashkin Donald P.   Celli Bartolome R.   Decramer Marc   Lystig Theodore   Liu Dacheng   Kesten Steven  

Publisher： Informa Healthcare

ISSN： 1541-2555

Source： COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol.9, Iss.3, 2012-05, pp. : 289-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Review of the Role of FEV1 in the COPD Paradigm

By Doherty Dennis  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 5, Iss. 5, 2008-10 ,pp. : 310-318

Informa Healthcare

Access to resources Recommend Favorite

Tiotropium Bromide: A Review of its Use as Maintenance Therapy in Patients with COPD

By Keam Susan J.   Keating Gillian M.  

Treatments in Respiratory Medicine, Vol. 3, Iss. 4, 2004-01 ,pp. : 247-268

Adis International

Access to resources Recommend Favorite

Using Post-bronchodilator FEV1 is Better Than Pre-bronchodilator FEV1 in Evaluation of COPD Severity

By Chen Chiung-Zuei   Ou Chih-Ying   Wang Wen-Ling   Lee Cheng-Hung   Lin Chien-Chung   Chang Han-Yu   Hsiue Tzuen-Ren  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 9, Iss. 3, 2012-05 ,pp. : 276-280

Informa Healthcare

Access to resources Recommend Favorite

Formoterol and Tiotropium Compared With Tiotropium Alone for Treatment of COPD

By Tashkin Donald   Pearle James   Iezzoni Domenic   Varghese Santosh  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 6, Iss. 1, 2009-02 ,pp. : 17-25

Informa Healthcare

Access to resources Recommend Favorite

Risk of Nonlower Respiratory Serious Adverse Events Following COPD Exacerbations in the 4-year UPLIFT ® Trial

By Halpin David  

Lung, Vol. 189, Iss. 4, 2011-08 ,pp. : 261-268

Springer Publishing Company

Access to resources Recommend Favorite